detect.comHealthcare / BioTech & PharmaFounded: 2018Funding to Date: $202.37MM
Detect leverages diagnostic testing technology to allow users to self-test at home for COVID-19. The Detect HubTM works in tandem with the DetectTM app to deliver results. Detect was founded in 2018 by Eric Abrams, Spencer Glantz, Owen Kaye-Kauderer, and Jonathan Rothberg Ph.D. and is headquartered in Guilford, CT.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
03/31/2022 | Series C-3 | $50.03MM | $xx.xx | $388.91MM | Undisclosedinvestors | |
Price per Share
$xx.xx
Shares Outstanding
39,706,508
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosedinvestors
|
||||||
03/31/2022 | Series C-2 | $54.79MM | $xx.xx | $388.91MM | Undisclosedinvestors | |
Price per Share
$xx.xx
Shares Outstanding
39,706,508
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosedinvestors
|
||||||
03/31/2022 | Series C-1 | $75MM | $xx.xx | $388.91MM | Undisclosedinvestors | |
Price per Share
$xx.xx
Shares Outstanding
43,859,650
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosedinvestors
|
||||||
01/15/2020 | Series B | $20MM | $xx.xx | $91.83MM | Undisclosedinvestors | |
Price per Share
$xx.xx
Shares Outstanding
23,529,412
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosedinvestors
|
||||||
06/15/2019 | Series A-2 | $831,803.00 | $xx.xx | $3.92MM | Undisclosedinvestors | |
Price per Share
$xx.xx
Shares Outstanding
18,776,602
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosedinvestors
|
||||||
06/15/2019 | Series A-1 | $1.72MM | $xx.xx | $3.92MM | Undisclosedinvestors | |
Price per Share
$xx.xx
Shares Outstanding
38,723,398
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosedinvestors
|